Art

J-GLOBAL ID：201902235436040396   Reference number：19A0724354

High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey

統合失調症の過体重入院患者における高密度リポ蛋白質-コレステロールと抗精神病薬の投薬:日本の全国調査の事後分析【JST・京大機械翻訳】

Author (21)： Ono Shin (Department of Community Psychiatric Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan) ,  Ono Shin (Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan) ,  Sugai Takuro (Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan) ,  Sugai Takuro (Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan) ,  Suzuki Yutaro (Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan) ,  Suzuki Yutaro (Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan) ,  Yamazaki Manabu (Japan Psychiatric Hospital Association, Tokyo, Japan) ,  Shimoda Kazutaka (Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan) ,  Shimoda Kazutaka (Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan) ,  Mori Takao (Japan Psychiatric Hospital Association, Tokyo, Japan) ,  Ozeki Yuji (Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan) ,  Ozeki Yuji (Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan) ,  Matsuda Hiroshi (Japan Psychiatric Hospital Association, Tokyo, Japan) ,  Sugawara Norio (Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan) ,  Sugawara Norio (Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan) ,  Yasui-Furukori Norio (Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan) ,  Yasui-Furukori Norio (Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan) ,  Okamoto Kurefu (Japan Psychiatric Hospital Association, Tokyo, Japan) ,  Sagae Toyoaki (Department of Health and Nutrition, Yamagata Prefectural Yonezawa University of Nutrition Sciences Faculty of Health and Nutrition, Yonezawa, Japan) ,  Someya Toshiyuki (Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan) ,  Someya Toshiyuki (Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan)
Material： BMC Psychiatry (Web)
Volume： 18  Issue： 1  Page： 180  Publication year： 2018 
JST Material Number： U7447A  ISSN： 1471-244X  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Patients with schizophrenia ha...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0724354&from=J-GLOBAL&jstjournalNo=U7447A") }}

Thesaurus term： questionnaire ,  *Body Weight ,  HDL cholesterol ,  side effect ,  *administration (biology) ,  morbidity ,  *antipsychotic agent ,  stratification ,  Metabolism ,  *schizophrenia ,  Japanese ,  *Inpatients ,  dopamine antagonist
Semi thesaurus term： *過体重 , 【Automatic Indexing@JST】

Author keywords (4)： Schizophrenia ,  Antipsychotics ,  High-density lipoprotein-cholesterol ,  Metabolic syndrome

JST classification (3)： Clinical application of psychotropic drugs  (GW03110J) ,  Epidemiology  (GB03000E) ,  Drug therapy(=pharmacotherapy)for mental disorders  (GR04020D)

Substance index (2)： Aripiprazole ,  Olanzapine

Reference (38)：

• Br J Psychiatry; Excess mortality of mental disorder; EC Harris, B Barraclough; 173; 1998; 11-53; 10.1192/bjp.173.1.11; citation_id=CR1
• Schizophr Bull; Prevalence and correlates of diabetes in national schizophrenia samples; L Dixon, P Weiden, J Delahanty, R Goldberg, L Postrado, A Lucksted; 26; 2000; 903-912; 10.1093/oxfordjournals.schbul.a033504; citation_id=CR2
• Schizophr Res; Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III; JP McEvoy, JM Meyer, DC Goff, HA Nasrallah, SM Davis, L Sullivan; 80; 2005; 19-32; 10.1016/j.schres.2005.07.014; citation_id=CR3
• Acta Psychiatr Scand; The metabolic syndrome and schizophrenia; JM Meyer, SM Stahl; 119; 2009; 4-14; 10.1111/j.1600-0447.2008.01317.x; citation_id=CR4
• Eur J Cardiovasc Prev Rehabil; Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review; DR Chirovsky, V Fedirko, Y Cui, V Sazonov, P Barter; 16; 2009; 404-423; 10.1097/HJR.0b013e32832c8891; citation_id=CR5

Terms in the title (10)： 統合失調症 ,  過体重 ,  入院患者 ,  高密度リポ蛋白質 ,  コレステロール ,  抗精神病薬 ,  投薬 ,  日本 ,  調査 ,  分析